Navigation Links
Labopharm Reports Results for Third Quarter Fiscal 2007
Date:11/9/2007

llars, except share

and per share amounts) $ $ $ $

-------------------------------------------------------------------------

REVENUE

Product sales 2,818 1,097 10,359 4,044

Licensing 1,058 2,229 4,786 6,672

Research and development

collaborations 1,217 - 1,217 -

-------------------------------------------------------------------------

5,093 3,326 16,362 10,716

-------------------------------------------------------------------------

EXPENSES

Cost of goods sold

(excluding amortization) 1,012 691 6,716 2,267

Research and development

expenses, net 7,171 2,611 17,088 12,466

Selling, general and

administrative expenses 4,596 4,069 16,048 11,060

Financial expenses 434 644 1,474 2,056

Impairment loss on

long-term investment 874 - 874 -

Depreciation and

amortization 510 430 1,482 1,276

Interest income (810) (1,271) (2,707) (2,277)

Foreign exchange loss (gain) (107) (50) 280 (643)

-------------------------------------------------------------------------

13,680 7,124 41,255 26,205

-------------------------------------------------------------------------

LOSS BEFORE INCOME TAXES (8,587) (3,798) (24,893) (15,489)

Provision for income taxes

Current 508 598 1,710 1,282

Future (64) (35) (64) (71)

-
'/>"/>

SOURCE Labopharm Inc.
Copyright©2007 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14

Related medicine news :

1. Labopharm To Present Poster On Onset Of Analgesic Effect Of Once-Daily Tramadol At Congress Of The European Society Of Regional Anaesthesia And Pain Therapy
2. Labopharm provides update on U.S. regulatory process for once-daily Tramadol
3. Labopharm completes enrolment for Phase III clinical study for its once-daily trazodone antidepressant drug
4. Labopharm appeals FDAs decision on once-daily tramadol
5. Labopharm to host conference call Friday, November 9, 2007 at 8:30 a.m. (ET)
6. Labopharm to present at CIBC World Markets 18th Annual Healthcare Conference
7. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
8. Haemacure Reports Third Quarter 2007 Results
9. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
10. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
11. MDS Reports Third Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2008)...exas Health Science Center at Houston will launch ...s (TEXAS), to promote geriatrics training for phys... the Donald W. Reynolds Foundation and $1.25 milli...ch geriatric medicine principles to everyone from ...icians. With the reach of Lyndon B. Johnson Genera...
(Date:11/21/2008)...ll/ -- The Providence Service,Corporation (Nasdaq...he Company,s,Chief Operating Officer, has been ap... Norris, appointment fills the vacancy left by the... returns the board to six members. Mr.,Norris wi... Mr. Norris, age 41, has been with Providence si...
(Date:11/21/2008)...nst Lennox-Gastaut syndrome , , FRIDAY, ...el (rufinamide) has been approved as a supplementa...Lennox-Gastaut syndrome, the U.S. Food and Drug Ad...as based on results of a four-month clinical trial...patients who took a placebo, those who took the dr...
(Date:11/21/2008)...ewswire/ -- New research at West Virginia Univers...bacco product aimed at young adults is catching on... Camel Snus - touted as a socially acceptable way ...levels of nicotine. , , "Camel Snus contain...aid Bruce Adkins of the state Division of Tobacco ...
Breaking Medicine News(10 mins):Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 2Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 3Health News:UT Houston launches geriatric training with $3.25 million in grant, matching funds 4Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:FDA Approves New Drug for Severe Epilepsy 2Health News:Experts Say New Tobacco Product Targets Young Adults 2Health News:Experts Say New Tobacco Product Targets Young Adults 3
...e ‘Mini’ Way to Stop Atrial Fibrillation in its Tr...ds of Americans with intermittent atrial fibrillat... of the Cox-Maze procedure //that involves scarrin...es sent by the brain to travel correctly. Richard ...
...bert Watson, a graduate student in the Section of ...f Medicine has found the uncommon path taken by Ca...s cells. Records show that, "campylobacteriosis,"...rhea worldwide, strikes 2.4 million Americans a ye...
...ala Lumpur: Five Malaysian states have registered ...first week of the year, with authorities fearing t...ead due to the rainy season, reports said Wednesda...an registered the highest jump, from 18 cases in t...
...new study finds that obesity increases the risk of...ot increase the overall risk a man will be diagnos... CANCER, a peer-reviewed journal of the American C... higher body mass index (BMI) and weight gain in a...
Other Medicine News:Health News:The Uncommon Pathway of Campylobacter Jejuni 2Health News:Mosquito-borne Dengue Disease on the Rise in Five Malaysian States 2Health News:Excess Weight and Adult Weight Gain Increase Risk of Prostate Cancer Death 2
(Date:11/20/2008)...NE RESULTS OF FIRST PHASE III TRIAL SHOW SIGNIFICA...EMENT IN DAILY FUNCTION, IN, ...if., and BRUSSELS, Belgium, Nov. 20 /PRNewswire-Fi... JAZZ ) and UCB (Euronext Brussels: UCB),announce... the first of two,Phase III pivotal clinical tria...
(Date:11/20/2008)... 20 Duska Therapeutics,... that it has submitted its,pivotal Phase 3 ATPace...l,Protocol Assessment (SPA) procedure with the U....ubject to securing an agreement with the FDA, Dusk...le-blind, placebo-controlled and randomized Phase ...
(Date:11/20/2008)...vember 20 The Scandinavian-based d...nced results of studies on its,lead antimicrobial...on, DC,the studies showed that the novel lytic p...fect, significantly better towards killing Staphyl...rketed gold standard drugs. In,addition to this i...
(Date:11/19/2008)...port basic findings on critical enzyme,s regulatio...t an array of disorders , , MEMPHIS, Tenn.,... St. Jude Children,s Research Hospital have gained... enzyme workhorses called calpains. , , As...tion in many cellular processes, including the mov...
Breaking Medicine Technology:Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 2Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 3Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 4Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 5Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia 6Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 2Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 3Duska Therapeutics Applies for Phase 3 Special Protocol Assessment 4Lytix Presents LTX-109 Anti-Microbial Data at ICAAC 2New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3National Federation of the Blind to Award 24100 000 7690 1National Federation of the Blind to Award 24100 000 7690 2Inspirational Medical Teachers Honored with Mentor Awards from the American Society of Hematology 7685 1Inspirational Medical Teachers Honored with Mentor Awards from the American Society of Hematology 7685 2ASH Holds a Special Symposium to Interest High School Students in Biomedical Research 2082 1ASH Holds a Special Symposium to Interest High School Students in Biomedical Research 2082 2New choices for patients 3A Transfusion free medicine for Jehovahs Witnesses and transfusion wary 7681 1New choices for patients 3A Transfusion free medicine for Jehovahs Witnesses and transfusion wary 7681 2
...IRE)--Mar 27, 2007 - Interleukin,Genetics, Inc. (A...lifornia San Diego today reported at the American ...ions between coronary artery,disease (CAD) and bot...ppear to be dependent on pro-inflammatory variants...tion titled "The Influence of Oxidized,Phospholipi...
...l for Vaccine Delivery System, NYON, Switzerland, ...Corporation announced today that the Company,s HIV...human primate model.,Mucosal IgA antibodies are co...infection by HIV. The data were presented by,Sylva...er in an,oral presentation, "Without Mucosal Adjuv...
Other Medicine Technology:ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 2ACC Presentation Indicates Interleukin-1 Gene Variants Determine,Increased Risk for Coronary Artery Disease from Oxidized,Phospholipids 3Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 2Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 3Mymetics' HIV Vaccine Achieves Research Breakthrough, Eliciting,Protective Antibody Response in Mucosal Tissues of Non-Human,Primate Model 4
Kaye Skin Hook, Single Prong
Designated most popular model or size.
Large deep curve.
Needle tip electrode, davol advantage electrosurgical attachments, 33cm (with extendible outer sheath), non-sterile. These products are supplied non-sterile and must be sterilized before use. Reusabl
Medicine Products: